These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6182059)

  • 21. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
    Flomenberg N; Welte K; Mertelsmann R; O'Reilly R; Dupont B
    J Immunol; 1983 Jun; 130(6):2635-43. PubMed ID: 6222110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer (NK) activity in children with acute lymphoblastic leukemia.
    Tanaka Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):127-33. PubMed ID: 6946050
    [No Abstract]   [Full Text] [Related]  

  • 24. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased natural killer cell activity in children with untreated acute leukemia.
    Nasrallah AG; Miale TD
    Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.
    Perussia B; Starr S; Abraham S; Fanning V; Trinchieri G
    J Immunol; 1983 May; 130(5):2133-41. PubMed ID: 6833758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Block of NK cell activity by ICO-11 monoclonal antibodies].
    Baryshnikov AIu; Trubcheninova LP; Savel'eva EV; Tupitsyn NN; Frenkel' MA
    Eksp Onkol; 1985; 7(3):34-6. PubMed ID: 3839452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Specific cellular immunity indices in acute leukemia in children].
    Osipov SG; Bergol'ts VM; Eremeev VS; Akimova GV; Rumiantsev AG
    Vopr Onkol; 1981; 27(1):20-2. PubMed ID: 7456440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural cytotoxicity in the guinea-pig: the natural killer (NK) cell activity of the Kurloff cell.
    Eremin O; Coombs RR; Ashby J; Plumb D
    Immunology; 1980 Oct; 41(2):367-78. PubMed ID: 7439932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between natural killer (NK) activity and eosinophil, neutrophil and lymphocyte level in human blood.
    Lasek WA; Płodziszewska M; Górecki D; Jakóbisiak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):907-12. PubMed ID: 2419220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer (NK) activity of normal human peripheral blood lymphocytes against erythroleukemic cell line K 562.
    Tanaka Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):115-26. PubMed ID: 6946049
    [No Abstract]   [Full Text] [Related]  

  • 34. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
    Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
    Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
    J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.